{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:04:16Z","timestamp":1762254256742,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.acvd.2022.05.008","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T14:17:01Z","timestamp":1662387421000},"page":"505-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry"],"prefix":"10.1016","volume":"115","author":[{"given":"Quentin","family":"Landolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Fajadet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Sainsous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Lhermusier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Elhadad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Tarragano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Ranc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00efd","family":"Ghostine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cayla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Garot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Motreff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Delarche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"De Labriolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Pansieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Morelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Cazaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Eric","family":"Moulichon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Chopat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Angoulvant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Le Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2022.05.008_bib0170","doi-asserted-by":"crossref","first-page":"16b","DOI":"10.1093\/eurheartj\/ehr384","article-title":"From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?","volume":"33","author":"Serruys","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2022.05.008_bib0175","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.acvd.2018.04.001","article-title":"Bioresorbable vascular scaffolds: time to absorb past lessons or fade away?","volume":"111","author":"de Pommereau","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2022.05.008_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.acvd.2018.09.007","article-title":"Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registry","volume":"112","author":"Cayla","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2022.05.008_bib0190","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2022.05.008_bib0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2022.05.008_bib0200","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2022.05.008_bib0205","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0210","first-page":"511","article-title":"Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry","volume":"98","author":"Lhermusier","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0215","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2022.05.008_bib0220","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/jbm.b.34605","article-title":"Structural optimization and finite element analysis of poly-l-lactide acid coronary stent with improved radial strength and acute recoil rate","volume":"108","author":"Song","year":"2020","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.acvd.2022.05.008_bib0225","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2022.05.008_bib0230","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2022.05.008_bib0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jcin.2011.04.009","article-title":"Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up","volume":"4","author":"Gomez-Lara","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0240","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.4244\/EIJ-D-19-01128","article-title":"Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy","volume":"16","author":"Kumar","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2022.05.008_bib0245","first-page":"533","article-title":"Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice\u00a0\u2013\u00a0results from the European Absorb Consortium","volume":"99","author":"Wiebe","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10554-011-9829-y","article-title":"Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT","volume":"28","author":"Gutierrez-Chico","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.acvd.2022.05.008_bib0255","first-page":"216","article-title":"Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: a meta-analysis","volume":"95","author":"Goel","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0260","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","article-title":"Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial","volume":"140","author":"Kereiakes","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2022.05.008_bib0265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamacardio.2019.4101","article-title":"Time-varying outcomes with the absorb bioresorbable vascular scaffold during 5-year follow-up: a systematic meta-analysis and individual patient data pooled study","volume":"4","author":"Stone","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0270","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4244\/EIJ-D-19-00773","article-title":"Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study","volume":"15","author":"Brugaletta","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2022.05.008_bib0275","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","article-title":"Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial","volume":"17","author":"Kerkmeijer","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2022.05.008_bib0280","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.4244\/EIJ-D-20-00024","article-title":"Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial","volume":"16","author":"Onuma","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2022.05.008_bib0285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jjcc.2019.01.012","article-title":"Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention","volume":"74","author":"Yano","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2020.01.037","article-title":"Exploring reasons for different bioresorbable scaffolds outcomes in women versus men: the research must go on","volume":"310","author":"Capranzano","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0295","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","article-title":"Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque","volume":"76","author":"Stone","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0300","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41569-018-0124-7","article-title":"Fully bioresorbable vascular scaffolds: lessons learned and future directions","volume":"16","author":"Jinnouchi","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0305","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jacc.2021.03.307","article-title":"Vascular lesion-specific drug delivery systems: JACC state-of-the-art review","volume":"77","author":"Marlevi","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2022.05.008_bib0310","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCRESAHA.117.310275","article-title":"Bioresorbable Scaffold: the emerging reality and future directions","volume":"120","author":"Sotomi","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2022.05.008_bib0315","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.4244\/EIJ-D-21-00651","article-title":"Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial","volume":"18","author":"Ortega-Paz","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2022.05.008_bib0320","first-page":"E1","article-title":"BIOSOLVE-IV-registry: safety and performance of the Magmaris scaffold: 12-month outcomes of the first cohort of 1,075 patients","volume":"98","author":"Verheye","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0325","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2022.05.008_bib0330","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","article-title":"Drug-coated balloon for de novo coronary artery disease: JACC state-of-the-art review","volume":"75","author":"Yerasi","year":"2020","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213622001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213622001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:47:49Z","timestamp":1761745669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213622001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1875213622001516"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2022.05.008","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2022.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}